Flag of the European Union EU Clinical Trials Register Help

Clinical trials for decitabine OR 2

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   44353   clinical trials with a EudraCT protocol, of which   7380   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    38,631 result(s) found for: decitabine OR 2. Displaying page 1,589 of 1,932.
    «« First « Previous 1585  1586  1587  1588  1589  1590  1591  1592  1593  Next» Last»»
    EudraCT Number: 2007-001389-34 Sponsor Protocol Number: PSD508-DYS-001 Start Date*: 2007-10-30
    Sponsor Name:Plethora Solutions Limited
    Full Title: A multi-centre, double-blind, placebo-controlled, multiple-dose crossover proof of concept study to compare the efficacy of mefenamic acid administered vaginally and orally in healthy menstruating ...
    Medical condition: Primary dysmenorrhoea requiring analgesia
    Disease: Version SOC Term Classification Code Term Level
    9.1 10036689 Primary dysmenorrhoea LLT
    Population Age: Adults Gender: Female
    Trial protocol: GB (Completed)
    Trial results: (No results available)
    EudraCT Number: 2010-018430-48 Sponsor Protocol Number: GEMCAD-09-02 Start Date*: 2010-05-20
    Sponsor Name:Grupo Español Multidisciplinar en cáncer Digestivo-GEMCAD
    Full Title: Estudio de fase II para evaluar la eficacia y la seguridad de la quimiorradioterapia con 5-fluorouracilo, mitomicina C y panitumumab como tratamiento del carcinoma anal de células escamosas
    Medical condition: Tratamiento de primera línea para pacientes con cáncer de células escamosas del canal anal locorregional
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: ES (Completed)
    Trial results: View results
    EudraCT Number: 2006-004036-71 Sponsor Protocol Number: 17-217 Start Date*: 2006-09-21
    Sponsor Name:Medizinische Universität Graz
    Full Title: Zur Frage des neuroleptikainduzierten metabolischen Syndroms. Studie 2: Fettverteilung und spezifische hormonelle Parameter. Vergleich zwischen auf das metabolische Syndrom vulnerablen und nicht vu...
    Medical condition: Bereits bekannte psychotische Erkrankung (Schizophrenie, schizoaffektive Störung, akut polymorph psychotische Störung) mit einer nicht tolerablen Gewichtssteigerung oder/und metabolischen Veränderu...
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: AT (Completed)
    Trial results: View results
    EudraCT Number: 2006-001823-20 Sponsor Protocol Number: CMA-0601-PR-0004 Start Date*: 2006-06-22
    Sponsor Name:CHIESI
    Full Title: A twelve-week, multicentre, double blind, randomised, parallel group, clinical study to assess the antihypertensive efficacy of delapril 15 mg b.i.d. and 30 mg b.i.d. versus lisinopril and placebo
    Medical condition: hypertension
    Disease: Version SOC Term Classification Code Term Level
    9.1 10015488 Essential hypertension LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Completed)
    Trial results: View results
    EudraCT Number: 2007-004795-39 Sponsor Protocol Number: LSO-OL005 Start Date*: 2008-06-12
    Sponsor Name:Light Sciences Oncology Inc.
    Full Title: A Phase III Randomised Study to Evaluate Survival of Patients Treated with Talaporfin Sodium (LS11) and Interstitial Light Emitting Diodes (LED) as Compared to the Standard of Care Therapies in the...
    Medical condition: Patients with unresectable hepatocellular carcinoma
    Disease: Version SOC Term Classification Code Term Level
    14.1 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) 10019828 Hepatocellular carcinoma non-resectable LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: PL (Completed) SE (Completed) IT (Completed)
    Trial results: (No results available)
    EudraCT Number: 2009-012596-94 Sponsor Protocol Number: GRACIA-4 Start Date*: 2009-11-10
    Sponsor Name:Fundación para la Investigación Biomédica del Hospital Gregorio Marañón
    Full Title: Estudio clínico aleatorizado comparativo entre angioplastia primaria y angioplastia postfibrinolisis como estrategias de reperfusión en pacientes con infarto agudo de miocardio con elevación del se...
    Medical condition: La hipótesis conceptual de este estudio es que en los pacientes con infarto agudo de miocardio y segmento ST elevado la angioplastia primaria es superior a una estrategia mixta de fibrinolisis inme...
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: ES (Completed)
    Trial results: (No results available)
    EudraCT Number: 2009-015743-16 Sponsor Protocol Number: NA Start Date*: 2009-10-09
    Sponsor Name:University Hospitals of Leicester NHS Trust
    Full Title: A randomised, partially observer-blind, multi-centre, head-to-head comparison of a two dose regimen of Baxter and GSK H1N1 pandemic vaccines, administered 21 days apart
    Medical condition: Pandemic H1N1 influenza.
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2009-015749-22 Sponsor Protocol Number: ADATOP Start Date*: 2010-12-22
    Sponsor Name:University of Leipzig
    Full Title: A prospective, monocentric clinical trial with adalimumab for topical treatment in chronic wounds
    Medical condition: Chronic stasis ulcer
    Disease: Version SOC Term Classification Code Term Level
    13.1 10040785 - Skin and subcutaneous tissue disorders 10047246 Venous stasis ulcer LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2008-001053-18 Sponsor Protocol Number: IC 2007-04 Start Date*: 2008-05-29
    Sponsor Name:INSTITUT CURIE
    Full Title: Étude de phase II randomisée évaluant une irradiation pelvienne associée au Cisplatine seul ou au Cisplatine plus Cetuximab chez des patientes présentant un carcinome du col utérin de stade IB2, II...
    Medical condition: Patientes présentant un cancer du col de l’utérus de type épidermoïde ou adénocarcinome de stade Ib2 à IIIb, non antérieurement traitées.
    Disease:
    Population Age: Adults, Elderly Gender: Female
    Trial protocol: FR (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2007-002983-89 Sponsor Protocol Number: BRD 07/3-Y Start Date*: 2007-10-12
    Sponsor Name:Centre Hospitalier Universitaire de Nantes
    Full Title: Intérêt de l’administration continue de ropivacaïne à l’aide du Pain – Buster™ dans la chirurgie des lambeaux microanastomosés de latissimus dorsi et de serratus
    Medical condition: Analgésie postopératoire suite à une chirurgie des lambeaux microanastomosés de latissimus dorsi et de serratus
    Disease: Version SOC Term Classification Code Term Level
    9.1 10024037 Latissimus dorsi flap LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: FR (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2009-017675-16 Sponsor Protocol Number: OFT113725 Start Date*: 2010-11-30
    Sponsor Name:Plymouth Hospitals NHS Trust
    Full Title: Phase II Trial of Single Agent Ofatumumab in Relapsed / Refractory Mantle Cell Lymphoma
    Medical condition: Relapsed or refractory Mantle Cell Lymphoma
    Disease: Version SOC Term Classification Code Term Level
    14.1 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) 10026800 Mantle cell lymphoma recurrent PT
    14.1 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) 10026801 Mantle cell lymphoma refractory PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: (No results available)
    EudraCT Number: 2009-009372-13 Sponsor Protocol Number: 2009-01b Start Date*: 2009-11-03
    Sponsor Name:Institut de Cancérologie de la Loire
    Full Title: A phase II, multi-center, open-label, repeat-dose study of Lenalidomide (Revlimid ®) plus low-dose Dexamethasone in patients with refractory B-cell lineage acute lymphoblastic leukemia or in relaps...
    Medical condition: Treatment for B-cell Acute lymphoblastic leukemia in relapse.
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: FR (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2012-004410-34 Sponsor Protocol Number: FOM_PER_1_12 Start Date*: 2013-01-11
    Sponsor Name:Cristina Peris Martínez
    Full Title: Influence of timolol maleate (ophthalmic gel 1 mg/g) on the keratometry and the parameters of corneal biomechanics in patients with keratoconus.
    Medical condition: Keratoconus
    Disease: Version SOC Term Classification Code Term Level
    14.1 10015919 - Eye disorders 10023353 Keratoconus PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: ES (Completed)
    Trial results: (No results available)
    EudraCT Number: 2010-020839-39 Sponsor Protocol Number: RA0056Amend4 Start Date*: 2011-02-25
    Sponsor Name:UCB Biosciences, Inc
    Full Title: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, DOSE RANGING STUDY WITH AN ACTIVE COMPARATOR TO EVALUATE THE EFFICACY AND SAFETY OF CDP6038 ADMINISTERED SUBCUTANEOUSLY FOR 12 WEEKS TO SUBJECTS WIT...
    Medical condition: Rheumatoid Arthritis
    Disease: Version SOC Term Classification Code Term Level
    14.1 10028395 - Musculoskeletal and connective tissue disorders 10039073 Rheumatoid arthritis PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Completed) BE (Completed)
    Trial results: View results
    EudraCT Number: 2011-001892-38 Sponsor Protocol Number: CTPN01 Start Date*: 2011-07-22
    Sponsor Name:Panin S.r.l.
    Full Title: A randomised, controlled, assessor-blind, clinical trial to compare Liceko ® with NIX/Lyclear 1% permethrin crème rinse in the treatment of head lice.
    Medical condition: Head louse infestation (pediculosis capitis)
    Disease: Version SOC Term Classification Code Term Level
    13.1 10021881 - Infections and infestations 10034214 Pediculus capitis (head louse) LLT
    Population Age: Children, Adolescents, Under 18, Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: (No results available)
    EudraCT Number: 2012-000870-51 Sponsor Protocol Number: CMCS240281 Start Date*: 2013-02-25
    Sponsor Name:Unidad de Gestión Clínica de Endocrinología y Nutrición
    Full Title: RANDOMIZED CLINICAL TRIAL TO ASSESS THE EFFICACY OF TESTOSTERONE UNDECANOATE, METFORMIN, OR THE COMBINATION OF BOTH, FOR THE TREATMENT OF ISOLATED HYPOGONADOTROPIC HYPOGONADISM AND ERECTILE DYSFUNC...
    Medical condition: Isolated hypogonadotropic hypogonadism related to obesity
    Disease:
    Population Age: Adults Gender: Male
    Trial protocol: ES (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2012-005480-28 Sponsor Protocol Number: IJG-FER-2012 Start Date*: 2013-05-21
    Sponsor Name:Institut d?Investigació en Atenció Primaria IDIAP Jordi Gol
    Full Title: Effectiveness of adaptation of the dose of iron supplementation in pregnancy on maternal-child health. Randomized clinical trial (ECLIPSES)
    Medical condition: Pregnant women, less than 12 week of gestations,without anemia (Hb <110 d / dL) in the pre-analytical at 12 weeks
    Disease:
    Population Age: Adults Gender: Female
    Trial protocol: ES (Completed)
    Trial results: (No results available)
    EudraCT Number: 2013-000711-24 Sponsor Protocol Number: 2013-000711-24 Start Date*: 2013-10-09
    Sponsor Name:Søren Rittig
    Full Title: The effect of combining anticholinergic treatment and transcutaneous electrical nerve stimulation in children suffering from daytime urinary incontinence and an overactive bladder.
    Medical condition: Daytime urinary incontinence and overactive bladder
    Disease: Version SOC Term Classification Code Term Level
    17.0 100000004857 10059617 Overactive bladder LLT
    Population Age: Children, Adolescents, Under 18 Gender: Male, Female
    Trial protocol: DK (Completed)
    Trial results: (No results available)
    EudraCT Number: 2008-000488-41 Sponsor Protocol Number: VALX00108 Start Date*: 2009-09-25
    Sponsor Name:PULEVA BIOTECH, S.A.
    Full Title: Ensayo clínico, multicentrico, aleatorizado, doble ciego, de grupos paralelos, para evaluar la eficacia del extracto de valeriana Valexxol frente a placebo, en la mejora subjetiva de la calidad del...
    Medical condition: Mejora de la calidad del sueño en pacientes con insomnio primario
    Disease: Version SOC Term Classification Code Term Level
    9.1 10036701 Primary insomnia LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: ES (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2012-001542-18 Sponsor Protocol Number: AAD-EU2012 Start Date*: 2012-07-12
    Sponsor Name:DuPont Nutrition and Health Active Nutrition
    Full Title: Effect of a probiotic formula on reducing the risk for antibiotic-associated diarrhea
    Medical condition: Antibiotic-associated diarrhea
    Disease: Version SOC Term Classification Code Term Level
    16.1 100000004856 10002739 Antibiotic-associated diarrhea LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: SE (Completed)
    Trial results: (No results available)
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    «« First « Previous 1585  1586  1587  1588  1589  1590  1591  1592  1593  Next» Last»»
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Mon Aug 11 06:10:24 CEST 2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA